Sat, Feb 27th, 2021
Subscribe
Log In
Lists
Book of Lists
The Money Issue
LA500
Wealthiest Angelenos
Health Care
Real Estate
Finance
Manufacturing
Tech
Infrastructure
Travel/Leisure
Media
Professional Services
Events
2021 Events
2020 Events
2019 Events
Custom Features
Custom Content
Trusted Advisors
People on the Move
Companies on the Move
Videos
×
Los Angeles Business Journal
Orange County Business Journal
San Diego Business Journal
San Fernando Valley Business Journal
Subscribe
Follow
Follow our NEWS
Facebook
Twitter
Instagram
LinkedIn
Follow our EVENTS
Facebook
Twitter
Instagram
Email Alerts
Log In
Search
×
Saturday, February 27, 2021
Sat, Feb 27th, 2021
Subscribe
Log In
Lists
Book of Lists
The Money Issue
LA500
Wealthiest Angelenos
Health Care
Real Estate
Finance
Manufacturing
Tech
Infrastructure
Travel/Leisure
Media
Professional Services
Events
2021 Events
2020 Events
2019 Events
Custom Features
Custom Content
Trusted Advisors
People on the Move
Companies on the Move
Videos
Home
2
NET WORTH:
$21.8 billion
AGE:
68
RESIDENCE:
Brentwood
SOURCE OF WEALTH:
Health care, investments, media
LAST YEAR:
$19.1 billion
CHANGE:
+14%
THE MONEY:
Soon-Shiong saw his stake in NantKwest Inc. and NantHealth Inc., his two publicly traded biotech companies, increase by more than $1 billion over the past year. NantKwest and Soon-Shiong’s privately held company ImmunityBio were selected to participate in the Trump administration’s Warp Speed program to fast-track development of Covid-19 vaccines. That news, combined with a small cancer treatment breakthrough earlier in the year, drove NantKwest shares up 10-fold and prompted a similar increase in Soon-Shiong’s privately held biotech portfolio companies. He also received a $710 million cash payout when Celgene Corp. — the company that bought his Abraxis Bioscience for $2.9 billion in 2010 — was sold last year to pharma giant Bristol Myers Squibb Co. His other holdings, including a 4.5% stake in the Los Angeles Lakers, a residential and commercial real estate portfolio, and an art collection, also saw significant increases in value. Not all was golden for Soon-Shiong, however. The Los Angeles Times is currently worth less than half of the $500 million Soon-Shiong paid for the paper and its related assets two years ago. And now that bankrupt Verity Health System’s assets have been distributed, Soon-Shiong — who had invested more than $300 million into the system prior to bankruptcy, making him its largest creditor — has on net received less than $250 million in bankruptcy court-approved payouts. That shortfall is in large part due to his $135 million purchase of St. Vincent Medical Center from bankrupt Verity.
THE BUZZ:
Soon-Shiong further raised his public profile in April when he purchased St. Vincent Medical Center in Westlake out of bankruptcy for $135 million and announced that the hospital would reopen to treat Covid-19 patents and host a coronavirus research center. He had initially proposed that the Chan Soon-Shiong Family Foundation, which he and his wife Michele Chan lead, would make the purchase. But when that idea ran into opposition from state Attorney General Xavier Becerra, Soon-Shiong bought the hospital out of his own pocket.
Return to the 2020 edition of the LA500.